Resting Full-cycle Ratio (RFR)-Guided Revascularization

NCT06075160 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1167

Last updated 2023-10-10

No results posted yet for this study

Summary

The purpose of this study is to compare the clinical outcomes of a 2-year follow-up to determine whether RFR-guided coronary intervention is non-inferior to FFR-guided coronary intervention in patients with intermediate coronary stenosis.

Conditions

Interventions

DIAGNOSTIC_TEST

Resting full-cycle ratio (RFR)-guided revascularization

The decision of coronary intervention is based on an RFR cut-value of 0.89. If RFR ≤ 0.89, target lesion will be revascularized, and if RFR \> 0.89, PCI will be deferred. However, even if RFR ≤ 0.89, PCI can be deferred if the RFR gradient of the lesion ≤ 0.02, or if the diffused type of stenosis, because physiological gain is expected to be very low.

DIAGNOSTIC_TEST

Fractional flow ratio (FFR)-guided revascularization

Study participants of FFR-guided PCI arm will be selected from a large-scaled, ongoing FFR registry. The decision of coronary intervention is based on an FFR cut-value of 0.80. If FFR ≤ 0.80, target lesion will be revascularized, and if RFR \> 0.80, PCI will be deferred.

Sponsors & Collaborators

  • Wonju Severance Christian Hospital

    collaborator OTHER
  • Hospital San Carlos, Madrid

    collaborator OTHER
  • Seoul St. Mary's Hospital

    collaborator OTHER
  • Dong-A University Hospital

    collaborator OTHER
  • Gyeongsang National University Hospital

    collaborator OTHER
  • Soon Chun Hyang University

    collaborator OTHER
  • Keimyung University Dongsan Medical Center

    collaborator OTHER
  • Ulsan University Hospital

    collaborator OTHER
  • Seoul National University Bundang Hospital

    collaborator OTHER
  • Kosin University Gospel Hospital

    collaborator OTHER
  • Pusan National University Hospital

    collaborator OTHER
  • Sejong General Hospital

    lead OTHER

Eligibility

Min Age
20 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-27
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06075160 on ClinicalTrials.gov